![Page 1: Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72](https://reader036.vdocuments.us/reader036/viewer/2022071807/56812a65550346895d8de242/html5/thumbnails/1.jpg)
Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363
Black Participants in the Study
Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72
![Page 2: Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72](https://reader036.vdocuments.us/reader036/viewer/2022071807/56812a65550346895d8de242/html5/thumbnails/2.jpg)
Distribution of Plasma LDL Cholesterol Levels (A) and Incidence
of Coronary Heart Disease (B) among Black Subjects, According
to the Presence or Absence of a PCSK9 142X or PCSK9 679X Allele
Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72
![Page 3: Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72](https://reader036.vdocuments.us/reader036/viewer/2022071807/56812a65550346895d8de242/html5/thumbnails/3.jpg)
The R46L-Encoding Allele of PCSK9 and Cardiovascular
Risk Factors among 9524 White Subjects in the Study*
Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72
![Page 4: Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72](https://reader036.vdocuments.us/reader036/viewer/2022071807/56812a65550346895d8de242/html5/thumbnails/4.jpg)
Distribution of Plasma LDL Cholesterol Levels (A)and Incidence
of Coronary Events (Panel B) among White Subjects, According
to the Presence or Absence of a PCSK9 46L Allele
Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72